SUBSCRIBE
SUBSCRIBE
News   Policy

Australian Therapeutic Goods Administration Pays Pan $55M After Recall Rethink

August 19, 2008 | 
1 min read
18-Aug-2008 -The Australian Therapeutic Goods Administration (TGA) will pay $55 million (€32.58m) to liquidated supplements manufacturer Pan Pharmaceuticals after inappropriately recalling the company’s entire 1600-product suite in 2003.
Regulatory Australia
MORE ON THIS TOPIC
Podcast
FDA Layoffs, 200 Rejection Letters, User Fees and Priority Vouchers, Bad Week for Rare Disease
July 16, 2025
 · 
1 min read
 · 
Heather McKenzie
Entrance to the U.S. Department of Health and Human Services in Washington, DC
Layoffs
HHS Begins Formally Laying Off Employees
July 15, 2025
 · 
2 min read
 · 
Tristan Manalac
Policy
FDA Commissioner Marty Makary Proposes Lowering Industry User Fees
July 15, 2025
 · 
2 min read
 · 
Tristan Manalac
World Management Team in office silhouette 3d rendering
Drug Development
The Gap Between the Administration’s Pro-Innovation Words and Policy
July 14, 2025
 · 
6 min read
 · 
Lori Ellis